Eli Lilly and Co., US5324571083

Lam Research stock holds near $302 after a strong quarter

Published on 08/31/2026 at 18:51 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Lam Research stock is holding near $302 after a quarter with $6.72 billion in revenue, $1.82 in EPS and a $0.13 beat versus consensus.

Architektur-Render eines gläsernen Firmensitzes mit Forschungscampus und Grünanlagen
Architektur-Render eines modernen Firmencampus visualisiert Eli Lilly and Company, ISIN US5324571083, als globalen Pharmakonzern, Illustration mit AI erstellt.

Lam Research stock (ISIN US5324571083) closed at $301.90 on August 30, 2026, with a market capitalization of $130.47 billion and a fresh earnings backdrop that put the latest quarter's revenue at $6.72 billion.

Quarterly beat still drives the tape

The latest quarter ended in July 2026 and delivered $1.82 in earnings per share versus a $1.69 consensus estimate, while revenue of $6.72 billion topped the $6.66 billion forecast. That $0.13 EPS beat and the 30 percent year-over-year revenue gain remain the main operating reference points for the shares.

Market data from August 30, 2026, also keeps the valuation discussion active, because the stock's $301.90 close came with a market cap above $130 billion. The move is best read as a stock that is trading on both earnings quality and a higher multiple than it carried earlier in the year.

Guidance and consensus

Management's current setup for fiscal first quarter 2027 points to EPS of $2.00 to $2.30, and that range gives investors a concrete near-term benchmark after the July 2026 quarter. Consensus data in the same August 31, 2026 coverage also shows an average rating of moderate buy and a target of $357.31, which leaves the shares below that level by more than $55.

The comparison matters because it ties the recent operating beat to the next reporting window, not just to a single quarter. Lam Research now needs another clean execution run to keep the earnings story aligned with the share price.

Product scale

Lam Research's wafer fabrication equipment business is the engine behind those numbers, and the latest quarter shows how tightly demand and profitability remain linked in advanced semiconductor manufacturing. Revenue of $6.72 billion and EPS of $1.82 indicate that the product cycle is still supporting strong cash generation.

Price check

The shares ended August 30, 2026, at $301.90 in Nasdaq trading, giving Lam Research a market cap of $130.47 billion as of that session.

Fact box

Company: Lam Research Corp.
ISIN: US5324571083
Ticker: LRCX
Exchange: Nasdaq
Price (as of August 30, 2026, 4:00 p.m. ET): $301.90 USD
Market cap: $130.47 billion (as of August 30, 2026)
Sector / Industry: Information Technology / Semiconductor Equipment
Index membership: Nasdaq-100

Disclaimer...

en | US5324571083 | ELI LILLY AND CO. | boerse | 70031388 | bgmi